133 related articles for article (PubMed ID: 15080858)
1. Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine.
Clemens B; Ménes A; Nagy Z
Acta Neurol Scand; 2004 May; 109(5):324-9. PubMed ID: 15080858
[TBL] [Abstract][Full Text] [Related]
2. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
Albani F; Baruzzi A;
Neurol Sci; 2006 Jul; 27(3):173-5. PubMed ID: 16897629
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
4. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings.
Clemens B; Ménes A; Piros P; Bessenyei M; Altmann A; Jerney J; Kollár K; Rosdy B; Rózsavölgyi M; Steinecker K; Hollódy K
Epilepsy Res; 2006 Aug; 70(2-3):190-9. PubMed ID: 16765028
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
Ahmad A; Garnett WR
Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
[TBL] [Abstract][Full Text] [Related]
6. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
7. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
Schmidt D; Elger CE
Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
[TBL] [Abstract][Full Text] [Related]
8. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy.
Vendrame M; Khurana DS; Cruz M; Melvin J; Valencia I; Legido A; Kothare SV
Epilepsia; 2007 Nov; 48(11):2116-20. PubMed ID: 17645535
[TBL] [Abstract][Full Text] [Related]
9. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures.
Sachdeo R; Beydoun A; Schachter S; Vazquez B; Schaul N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2001 Sep; 57(5):864-71. PubMed ID: 11552018
[TBL] [Abstract][Full Text] [Related]
10. Oxcarbazepine versus carbamazepine in the treatment of paroxysmal kinesigenic dyskinesia.
Yang Y; Su Y; Guo Y; Ding Y; Xu S; Jiang Y; Wang S; Ding M
Int J Neurosci; 2012 Dec; 122(12):719-22. PubMed ID: 22856516
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
[TBL] [Abstract][Full Text] [Related]
12. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis.
Lee WC; Hoffmann MS; Arcona S; D'Souza J; Wang Q; Pashos CL
Clin Ther; 2005 Oct; 27(10):1629-38. PubMed ID: 16330300
[TBL] [Abstract][Full Text] [Related]
13. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A
Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683
[TBL] [Abstract][Full Text] [Related]
14. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT.
Croissant B; Loeber S; Diehl A; Nakovics H; Wagner F; Kiefer F; Mann K
Pharmacopsychiatry; 2009 Sep; 42(5):175-81. PubMed ID: 19724979
[TBL] [Abstract][Full Text] [Related]
16. Teratogenicity of carbamazepine-10, 11-epoxide and oxcarbazepine in the SWV mouse.
Bennett GD; Amore BM; Finnell RH; Wlodarczyk B; Kalhorn TF; Skiles GL; Nelson SD; Slattery JT
J Pharmacol Exp Ther; 1996 Dec; 279(3):1237-42. PubMed ID: 8968346
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus.
Giustizieri M; Armogida M; Berretta N; Federici M; Piccirilli S; Mercuri NB; Nistico R
Synapse; 2008 Oct; 62(10):783-9. PubMed ID: 18655118
[TBL] [Abstract][Full Text] [Related]
18. Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results.
Massot A; Vivanco R; Principe A; Roquer J; Rocamora R
Neurologia; 2014 Mar; 29(2):94-101. PubMed ID: 23623701
[TBL] [Abstract][Full Text] [Related]
19. [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].
Homberg V; Kowalik A; Schulze-Bonhage A
Nervenarzt; 2001 Dec; 72(12):918-23. PubMed ID: 11789435
[TBL] [Abstract][Full Text] [Related]
20. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
